BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2026.
World J Gastrointest Endosc. Feb 16, 2026; 18(2): 114400
Published online Feb 16, 2026. doi: 10.4253/wjge.v18.i2.114400
Table 2 Perioperative and follow-up outcomes of patients with submucosal tumors before and after inverse probability of treatment weighting adjustment, n (%)
VariablesBefore IPTW adjustment
After IPTW adjustment
ESD (n = 48)
Precutting EBL (n = 46)
Significance (P value)
ESD (n = 93.97)
Precutting EBL (n = 94.27)
Significance (P value)
Procedure duration, minutes
Median (IQR)46 (40-50)17 (16-18)< 0.00146.00 (40.00-49.56)17.00 (16.00-18.00)< 0.001
Adverse events5 (10.42)00.07310.78 (11.47)0.00 (0.00)0.024
Cost of operation
Median (IQR), dollars1754.48 (1585.08-1843.45)525.33 (507.59-657.71)< 0.0011751.72 (1557.30-1852.06)515.57 (507.59-627.14)< 0.001
Patient type--< 0.001--< 0.001
Outpatient0 (0.00)15 (32.61)-0.00 (0.00)29.09 (30.86)-
Inpatient48 (100.00)31 (67.39)-93.97 (100.00)65.18 (69.14)-
Follow-up time, months
Median (IQR)48 (48-60)54 (36-84)0.39448.60 (48.00-60.00)52.00 (36.00-84.00)0.398
Local recurrence--NA--NA
No recurrence48 (100.00)46 (100.00)-93.97 (100.00)94.27 (100.00)-
Recurrence0 (0)0 (0)-0 (0)0 (0)-


Write to the Help Desk